propafenone has been researched along with Cardiac Complex, Premature in 50 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 12 patients with coronary artery disease, 11 of them with previous myocardial infarction, the antiarrhythmic effects of orally administered flecainide (F." | 9.05 | [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. ( Fabry, E; Klempt, HW; Nayebagha, A, 1982) |
| "105 sequential patients with ventricular arrhythmias in a basal ECG-H recording, that were evaluated within 1 year with a new recording on amiodarone or propafenone, without major clinical events or therapeutic changes between the two recordings." | 7.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "The antiarrhythmic efficacy of Propafenone (PF) was evaluated in 24 patients with ventricular hyperkinetic arrhythmias by means of 24-hour Holter monitoring." | 7.67 | [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. ( Cappiello, E; Garimoldi, M; Pirastu, A; Sala, R; Sghirinzetti, M; Terranova, P, 1986) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 7.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "Forty-seven patients with chronic atrial fibrillation and (or) flutter in whom the clinical picture and the length of arrhythmia indicated that drug-mediated cardioversion should be tried were treated with a combination of lidoflazine and propafenon." | 7.66 | [Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]. ( Beck, OA; Hochrein, H, 1980) |
| "The anti-arrhythmic drug mexiletine caused an oesophageal ulcer, confirmed by endoscopy and biopsy, in a 72-year-old woman." | 7.66 | [Esophageal ulcer caused by mexiletine]. ( Rudolph, R; Seckfort, H; Seggewiss, H, 1983) |
| "Diprafenone is a new antiarrhythmic agent with a dominant local anesthetic action and additional beta-sympathicolytic activity." | 6.66 | [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone]. ( Geibel, A; Hohnloser, S; Just, H; Landsrath, C; Meinertz, T; Zehender, M, 1988) |
| " Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not." | 5.29 | Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994) |
| "Propafenone, three times 150 mg/d over 33 days and two years later at the same dosage over six days, was administered to an 84-year-old man with ventricular extrasystoles (Lown IVa)." | 5.27 | [Cholestasis after antiarrhythmic therapy with propafenone]. ( Berg, PA; Konz, KH; Seipel, L, 1984) |
| "Propafenone was less effective (mean effect 3." | 5.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "In 12 patients with coronary artery disease, 11 of them with previous myocardial infarction, the antiarrhythmic effects of orally administered flecainide (F." | 5.05 | [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. ( Fabry, E; Klempt, HW; Nayebagha, A, 1982) |
| "The electrophysiological effects of combination therapy of mexiletine and propafenone were assessed using standard 12-lead electrocardiogram (standard ECG), signal-averaged ECG (SAECG), and ambulatory ECG in 31 patients with ventricular arrhythmias." | 3.68 | Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy. ( Haruna, M; Kato, H; Lee, S; Machii, T; Nonokawa, M; Takanaka, C; Yabe, S, 1992) |
| "105 sequential patients with ventricular arrhythmias in a basal ECG-H recording, that were evaluated within 1 year with a new recording on amiodarone or propafenone, without major clinical events or therapeutic changes between the two recordings." | 3.68 | [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. ( Adragão, P; Bonhorst, D; Seabra-Gomes, R; Ventosa, A, 1990) |
| "The antiarrhythmic efficacy of Propafenone (PF) was evaluated in 24 patients with ventricular hyperkinetic arrhythmias by means of 24-hour Holter monitoring." | 3.67 | [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. ( Cappiello, E; Garimoldi, M; Pirastu, A; Sala, R; Sghirinzetti, M; Terranova, P, 1986) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 3.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "Forty-seven patients with chronic atrial fibrillation and (or) flutter in whom the clinical picture and the length of arrhythmia indicated that drug-mediated cardioversion should be tried were treated with a combination of lidoflazine and propafenon." | 3.66 | [Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]. ( Beck, OA; Hochrein, H, 1980) |
| "The anti-arrhythmic drug mexiletine caused an oesophageal ulcer, confirmed by endoscopy and biopsy, in a 72-year-old woman." | 3.66 | [Esophageal ulcer caused by mexiletine]. ( Rudolph, R; Seckfort, H; Seggewiss, H, 1983) |
| " After a period of placebo administration, all patients underwent three consecutive periods during which they received Pr IR at the dosage of 150 mg x 3, Pr SR at the dosage of 225 mg x 2, Pr SR at the dosage of 325 mg x 2." | 2.69 | [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms]. ( Massari, F; Mastropasqua, F; Pitzalis, MV; Rizzon, P; Totaro, P, 1998) |
| "Propafenone was administered in doses of 450 and 900 mg/day, during 5-7 days, at which moment another HM and esophageal stimulation were repeated." | 2.68 | [Use-dependence of propafenone. Clinical demonstration of the hypothesis of modulated receptors]. ( González Zuelgaray, J; Labadet, CD; Peralta, A, 1995) |
| "Amiodarone was well tolerated and propafenone produced minor digestive and neurosensory troubles in about half the cases, only in one patient a more pronounced arrhythmogenic effect was observed." | 2.66 | [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole]. ( Cosnay, P; Fauchier, JP; Huguet, R; Moquet, B; Rouesnel, P; Wajman, A, 1986) |
| " Increase of the dosage to 900 mg does not improve significantly the anti-arrhythmic efficacy while the side effects seem more frequent." | 2.66 | [Propafenone in ventricular extrasystole in elderly patients. Tolerance and efficacy]. ( Baudouy, M; Benoit, P; Camous, JP; Gibelin, P; Morand, P; Schenowitz, A; Varenne, A; Vrancea, F, 1987) |
| "Diprafenone is a new antiarrhythmic agent with a dominant local anesthetic action and additional beta-sympathicolytic activity." | 2.66 | [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone]. ( Geibel, A; Hohnloser, S; Just, H; Landsrath, C; Meinertz, T; Zehender, M, 1988) |
| " With the intravenous administration of the drug in a dosage of 1." | 2.65 | [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)]. ( Eigster, G; Weber, H; Wesselhoeft, H, 1981) |
| "The frequency of extrasystoles decreased on propafenon alone by 70% (P less than 0." | 2.65 | [Propafenon and propranolol in the management of cardiac extrasystoles (author's transl)]. ( Beck, OA; Hochrein, H; Ihle, C, 1982) |
| " Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not." | 1.29 | Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994) |
| "Propafenone was given as a bolus injection of 1." | 1.29 | [Evaluation of the clinical acute electrophysiological effects of propafenone using transesophageal atrial pacing]. ( Cheng, X; He, F; Zhao, X, 1994) |
| " Conduction disorders were present with a propafenone dosage or on preexisting conduction anomalies." | 1.28 | [Long-term study of propafenone in severe ventricular extrasystole in elderly subjects]. ( Diadema, B; Escande, M; Maarek-Charbit, M, 1989) |
| "Propafenone, three times 150 mg/d over 33 days and two years later at the same dosage over six days, was administered to an 84-year-old man with ventricular extrasystoles (Lown IVa)." | 1.27 | [Cholestasis after antiarrhythmic therapy with propafenone]. ( Berg, PA; Konz, KH; Seipel, L, 1984) |
| "Propafenone was less effective (mean effect 3." | 1.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (74.00) | 18.7374 |
| 1990's | 13 (26.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, OA | 3 |
| Hochrein, H | 3 |
| Klein, G | 1 |
| Wirtzfeld, A | 1 |
| Schlegl, J | 1 |
| Himmler, C | 1 |
| Neiss, A | 1 |
| Meyer-Estorf, G | 1 |
| Keller, K | 1 |
| Körst, HA | 1 |
| Brandes, JW | 1 |
| Littmann, KP | 1 |
| Giannini, SD | 1 |
| Zillioto, EE | 1 |
| Campanari, JC | 1 |
| Formicola, A | 1 |
| Weber, H | 1 |
| Eigster, G | 1 |
| Wesselhoeft, H | 1 |
| Ihle, C | 1 |
| Klempt, HW | 1 |
| Nayebagha, A | 1 |
| Fabry, E | 1 |
| da Silva, MA | 1 |
| Fragata Filho, AA | 1 |
| Boainain, E | 1 |
| Magalhães, HM | 1 |
| Kenedi, P | 1 |
| Porto, CC | 1 |
| Guimarães, E | 1 |
| Rosa, J | 1 |
| Rassi, A | 1 |
| Lüderitz, B | 1 |
| Rudolph, R | 1 |
| Seggewiss, H | 1 |
| Seckfort, H | 1 |
| Rizzon, P | 2 |
| De Toma, L | 1 |
| Mangini, SG | 1 |
| Lagioia, R | 1 |
| Scrutinio, D | 1 |
| Accettura, D | 1 |
| De Nicolò, M | 1 |
| Konz, KH | 1 |
| Berg, PA | 1 |
| Seipel, L | 1 |
| Coumel, P | 1 |
| Leclercq, JF | 1 |
| Assayag, P | 1 |
| Dimitrov, D | 1 |
| Heusch, A | 1 |
| Kramer, HH | 1 |
| Krogmann, ON | 1 |
| Rammos, S | 1 |
| Bourgeous, M | 1 |
| He, F | 1 |
| Zhao, X | 1 |
| Cheng, X | 1 |
| Labadet, CD | 1 |
| Peralta, A | 1 |
| González Zuelgaray, J | 1 |
| Palazzuoli, V | 2 |
| Mondillo, S | 2 |
| Faglia, S | 2 |
| D'Aprile, N | 2 |
| Camporeale, A | 1 |
| Gennari, C | 1 |
| Lardoux, H | 1 |
| Valère, PE | 1 |
| Djiane, P | 1 |
| Maarek-Charbit, M | 2 |
| Mangiacotti, L | 1 |
| Campolo, MA | 1 |
| Agricola, E | 1 |
| Dobrotvorskaia, TE | 1 |
| Koroleva, ON | 1 |
| Gordina, OV | 1 |
| Marakanova, AV | 1 |
| Mastropasqua, F | 1 |
| Totaro, P | 1 |
| Massari, F | 1 |
| Pitzalis, MV | 1 |
| de Brito, FS | 1 |
| Pereira, MH | 1 |
| Castro, I | 1 |
| Maia, IG | 1 |
| Takanaka, C | 1 |
| Nonokawa, M | 1 |
| Machii, T | 1 |
| Lee, S | 1 |
| Kato, H | 1 |
| Haruna, M | 1 |
| Yabe, S | 1 |
| Lombardi, F | 1 |
| Torzillo, D | 1 |
| Sandrone, G | 1 |
| Dalla Vecchia, L | 1 |
| Cappiello, E | 2 |
| Gillor, A | 1 |
| Korsch, E | 1 |
| Ventosa, A | 1 |
| Adragão, P | 1 |
| Bonhorst, D | 1 |
| Seabra-Gomes, R | 1 |
| Nielsen, H | 1 |
| Sørum, C | 1 |
| Rasmussen, V | 1 |
| Madsen, JK | 1 |
| Hansen, JF | 1 |
| Korsukewitz, J | 1 |
| Wegscheider, K | 1 |
| Schmutzler, H | 1 |
| Ferrara, E | 1 |
| Vitali, A | 1 |
| Cucchi, GF | 1 |
| Garimoldi, M | 1 |
| Sghirinzetti, M | 1 |
| Pirastu, A | 1 |
| Sala, R | 1 |
| Terranova, P | 1 |
| Frabetti, L | 2 |
| Marchesini, B | 2 |
| Capucci, A | 2 |
| Cavallini, C | 1 |
| Gubelli, S | 1 |
| Ambrosioni, E | 2 |
| Magnani, B | 2 |
| Fauchier, JP | 1 |
| Cosnay, P | 1 |
| Rouesnel, P | 1 |
| Moquet, B | 1 |
| Huguet, R | 1 |
| Wajman, A | 3 |
| Tomaszewski, A | 1 |
| Kleinrok, A | 1 |
| Rumiński, W | 1 |
| Markiewicz, M | 1 |
| Camous, JP | 1 |
| Benoit, P | 1 |
| Vrancea, F | 1 |
| Gibelin, P | 1 |
| Schenowitz, A | 1 |
| Baudouy, M | 1 |
| Varenne, A | 1 |
| Morand, P | 2 |
| Libersa, C | 1 |
| Caron, J | 1 |
| Pladys, A | 1 |
| Beuscart, R | 1 |
| Kacet, S | 1 |
| Connell, C | 1 |
| Dupuis, B | 1 |
| Lekieffre, J | 1 |
| Li, ZS | 1 |
| Henze, E | 1 |
| Roth, J | 1 |
| Haerer, W | 1 |
| Adam, WE | 1 |
| Stauch, M | 1 |
| Geibel, A | 1 |
| Zehender, M | 1 |
| Hohnloser, S | 1 |
| Landsrath, C | 1 |
| Meinertz, T | 1 |
| Just, H | 1 |
| Liusov, VA | 1 |
| Borodkin, VV | 1 |
| Volov, NA | 1 |
| Dudaev, VA | 1 |
| Boriani, G | 1 |
| Balducelli, M | 1 |
| Tomasi, L | 1 |
| Drici, MD | 1 |
| Sbirrazzuoli, V | 1 |
| Garraffo, R | 1 |
| Lapalus, P | 1 |
| Escande, M | 1 |
| Diadema, B | 1 |
| Lukasik, S | 1 |
| Nowosad, H | 1 |
| Grzelak, H | 1 |
| Kowalewski, W | 1 |
| Kowalisko, A | 1 |
| Jack, RA | 1 |
| Petri, H | 1 |
| Kafka, W | 1 |
| Rudolph, W | 1 |
| Aguglia, F | 1 |
| Gnecchi, M | 1 |
| De Marzio, P | 1 |
25 trials available for propafenone and Cardiac Complex, Premature
| Article | Year |
|---|---|
[Efficacy of anti-arrhythmia agents].
Topics: Adult; Aged; Ajmaline; Androstanols; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical | 1980 |
[Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
Topics: Adolescent; Age Factors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Atrioventricu | 1981 |
[Propafenon and propranolol in the management of cardiac extrasystoles (author's transl)].
Topics: Adult; Aged; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; Female; H | 1982 |
[Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Disease; Electrocardiogr | 1982 |
[Evaluation of propafenon in Chagas patients with ventricular extrasystole].
Topics: Adult; Blood Pressure; Cardiac Complexes, Premature; Chagas Cardiomyopathy; Clinical Trials as Topic | 1981 |
[Propafenon in the prevention of ventricular extrasystole of Chagas etiology related to physical effort. Evaluation by cycloergometry].
Topics: Adult; Cardiac Complexes, Premature; Chagas Cardiomyopathy; Clinical Trials as Topic; Electrocardiog | 1982 |
[Comparison of the efficacy of propafenone and hydroquinidine in stabilized extrasystolic ventricular arrhythmia by means of dynamic electrocardiographic Holter monitoring].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Double-Blind Method; Drug A | 1984 |
[Treatment of chronic ventricular extrasystole with propafenone (Rhythmonorm)].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Chronic Disease; Clin | 1984 |
[Use-dependence of propafenone. Clinical demonstration of the hypothesis of modulated receptors].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiac Comp | 1995 |
[The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy].
Topics: Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Carnitine; Drug Therapy, Combination; El | 1993 |
[Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cardiac Complexes, Premature; Chronic Disease; | 1993 |
[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Carnitine; Drug Sy | 1995 |
[Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
Topics: Angina Pectoris; Angina, Unstable; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Di | 1996 |
[Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Do | 1998 |
[Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Female; H | 1979 |
Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
Topics: Adult; Aged; Cardiac Complexes, Premature; Chronic Disease; Delayed-Action Preparations; Double-Blin | 1990 |
[Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; | 1985 |
Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Tr | 1986 |
[Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Pre | 1986 |
[Propafenone in ventricular extrasystole in elderly patients. Tolerance and efficacy].
Topics: Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Drug Tolerance; Humans; Propafenone | 1987 |
Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
Topics: Adult; Aged; Cardiac Complexes, Premature; Chronic Disease; Disopyramide; Double-Blind Method; Femal | 1987 |
Long term inotropic effects of flecainide and propafenone.
Topics: Administration, Oral; Adult; Cardiac Complexes, Premature; Clinical Trials as Topic; Exercise Test; | 1988 |
[Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as | 1988 |
[Multicenter comparative studies of the effectiveness and tolerance of propafenone and disopyramide in the treatment of premature ventricular beats].
Topics: Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Drug Tolerance; F | 1987 |
[Therapy of ventricular arrhythmias with propafenone].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Pac | 1985 |
25 other studies available for propafenone and Cardiac Complex, Premature
| Article | Year |
|---|---|
[Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)].
Topics: Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Chronic Disease; Drug Therapy, Co | 1980 |
[Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)].
Topics: Adult; Aged; Cardiac Complexes, Premature; Electrocardiography; Female; Heart Conduction System; Hum | 1980 |
[Disturbances of potency and spermiogenesis due to propafenon (author's transl)].
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Erectile Dysfunction; Humans; Male; Pro | 1980 |
[Value of propafenon in the control of ventricular extrasystolic arrhythmia. Clinical, electrocardiographic and laboratory evaluation in prolonged use].
Topics: Adolescent; Adult; Aged; Cardiac Complexes, Premature; Chagas Cardiomyopathy; Electrocardiography; F | 1980 |
[Effectiveness of propafenon and disopyramide in ventricular extrasystole. Comparative study].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Female; Heart Ventr | 1982 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
[Esophageal ulcer caused by mexiletine].
Topics: Aged; Cardiac Complexes, Premature; Esophageal Diseases; Female; Hemoptysis; Humans; Male; Mexiletin | 1983 |
[Cholestasis after antiarrhythmic therapy with propafenone].
Topics: Aged; Cardiac Complexes, Premature; Cholestasis; Humans; Lymphocyte Activation; Male; Propafenone; P | 1984 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1984 |
Clinical experience with propafenone for cardiac arrhythmias in the young.
Topics: Administration, Oral; Adolescent; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Premature | 1994 |
[Evaluation of the clinical acute electrophysiological effects of propafenone using transesophageal atrial pacing].
Topics: Adolescent; Adult; Aged; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Female; Humans; M | 1994 |
Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography; | 1992 |
Autonomic effects of antiarrhythmic drugs and their importance.
Topics: Adult; Autonomic Nervous System; Cardiac Complexes, Premature; Electrocardiography; Female; Flecaini | 1992 |
[Familial manifestation of idiopathic atrial flutter].
Topics: Adolescent; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Child; Digoxin; Drug | 1992 |
[Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrocardiography, Am | 1990 |
[Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Evaluation; Electrocardiogra | 1985 |
[Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bundle-Branch Block; Cardiac Complexes, Prematur | 1986 |
[Polycardiographic evaluation of the dynamics of left ventricular contraction in patients treated with disopyramide and propafenone].
Topics: Adult; Cardiac Complexes, Premature; Disopyramide; Electrocardiography; Female; Heart Ventricles; Hu | 1986 |
[Antiarrhythmic effect and blood levels of propafenone].
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Complexes, Premature; Chromatography, High Pressure Liquid | 1987 |
[Use of prolecofen in the treatment of arrhythmia in patients with ischemic heart disease].
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Complexes, Premature; Coronary Disease; Female; Hemostasis | 1989 |
[Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Evaluati | 1988 |
Effect of propafenone hydrochloride on lymphocyte membrane beta 2 adrenoceptors in ventricular arrhythmias.
Topics: Adult; Cardiac Complexes, Premature; Cell Membrane; Electrocardiography; Female; Humans; Iodine Radi | 1989 |
[Long-term study of propafenone in severe ventricular extrasystole in elderly subjects].
Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Female; Huma | 1989 |
A case of mania secondary to propafenone.
Topics: Adult; Anti-Arrhythmia Agents; Bipolar Disorder; Bupropion; Cardiac Complexes, Premature; Female; Hu | 1985 |
Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Dru | 1985 |